LEP and obesity due to melanocortin 4 receptor deficiency: Since the cardiac hormones increase lipolysis in obese subjects, as well as helping to alleviate obesity-interrelated hypertension mediated by leptin, this suggests they may be a multi-targeted novel therapy for obesity.